<?xml version='1.0' encoding='utf-8'?>
<document id="26805594"><sentence text="Use of 4β-hydroxycholesterol in animal and human plasma samples as a biomarker for CYP3A induction."><entity charOffset="7-28" id="DDI-PubMed.26805594.s1.e0" text="4β-hydroxycholesterol" /></sentence><sentence text="4β-hydroxycholesterol (4βHC) has recently been proposed as a potential endogenous biomarker for CYP3A activity"><entity charOffset="0-21" id="DDI-PubMed.26805594.s2.e0" text="4β-hydroxycholesterol" /><entity charOffset="23-27" id="DDI-PubMed.26805594.s2.e1" text="4βHC" /><pair ddi="false" e1="DDI-PubMed.26805594.s2.e0" e2="DDI-PubMed.26805594.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26805594.s2.e0" e2="DDI-PubMed.26805594.s2.e1" /></sentence><sentence text=" Developing bioanalytical assays for 4βHC is challenging for several reasons, including endogenous background levels in plasma; the presence of free and ester forms; the inherent lack of MS sensitivity; and the presence of multiple positional isomers"><entity charOffset="153-158" id="DDI-PubMed.26805594.s3.e0" text="ester" /><entity charOffset="37-41" id="DDI-PubMed.26805594.s3.e1" text="4βHC" /><pair ddi="false" e1="DDI-PubMed.26805594.s3.e1" e2="DDI-PubMed.26805594.s3.e1" /><pair ddi="false" e1="DDI-PubMed.26805594.s3.e1" e2="DDI-PubMed.26805594.s3.e0" /></sentence><sentence text="" /><sentence text="Bioanalytical assays in mouse, rat, dog and human plasma were adapted and modified from a previous published human plasma assay for 4βHC by using alkaline de-esterification, picolinic derivatization, a surrogate analyte (d7-4βHC) in authentic matrices and chromatographic conditions that showed good separation from isobaric, positional isomers"><entity charOffset="132-135" id="DDI-PubMed.26805594.s5.e0" text="4βHC" /><entity charOffset="224-227" id="DDI-PubMed.26805594.s5.e1" text="4βHC" /><entity charOffset="158-161" id="DDI-PubMed.26805594.s5.e2" text="ester" /><pair ddi="false" e1="DDI-PubMed.26805594.s5.e0" e2="DDI-PubMed.26805594.s5.e0" /><pair ddi="false" e1="DDI-PubMed.26805594.s5.e0" e2="DDI-PubMed.26805594.s5.e2" /><pair ddi="false" e1="DDI-PubMed.26805594.s5.e0" e2="DDI-PubMed.26805594.s5.e1" /><pair ddi="false" e1="DDI-PubMed.26805594.s5.e2" e2="DDI-PubMed.26805594.s5.e2" /><pair ddi="false" e1="DDI-PubMed.26805594.s5.e2" e2="DDI-PubMed.26805594.s5.e1" /></sentence><sentence text="" /><sentence text="These assays were applied to multiple studies and demonstrated potential applications of 4βHC as a CYP3A biomarker across preclinical and clinical settings"><entity charOffset="89-93" id="DDI-PubMed.26805594.s7.e0" text="4βHC" /></sentence><sentence text="" /></document>